- In recent days, analysts’ forecasts for Amcor’s upcoming quarterly results have pointed to earnings of $1.20 per share, with revenues and both flexible and rigid packaging segments expected to grow meaningfully year over year.
- This upbeat view of broad-based segment growth suggests analysts see operational momentum across Amcor’s core packaging businesses rather than a narrow, one-off improvement.
- We’ll now examine how these stronger-than-expected earnings projections, particularly for rigid packaging, may influence Amcor’s existing investment narrative.
AI is about to change healthcare. These 43 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
Amcor Investment Narrative Recap
To own Amcor, you need to believe its broad packaging platform, Berry merger integration and portfolio reshaping can translate into steadier earnings and cash generation. The latest consensus call for US$1.20 EPS on nearly 20% revenue growth highlights rigid packaging as a key short term catalyst, but it does not fully resolve concerns around weak volumes, high leverage and the sizable portfolio under review. Overall, this earnings upside does not yet remove the biggest risk around portfolio execution and divestiture outcomes.
Against this backdrop, the ongoing quarterly dividends, including the recent US$0.65 per share declaration, remain highly relevant. They underline Amcor’s commitment to returning cash even as it funds integration costs, elevated capex and debt reduction efforts. For investors, this creates a tension between the attraction of a sizable yield and the risk that limited free cash flow coverage, together with higher leverage, could constrain future flexibility if earnings or asset sale proceeds disappoint.
Yet beneath the stronger earnings forecasts, the real risk investors should be aware of is how much Amcor still depends on portfolio sales and restructuring costs...
Read the full narrative on Amcor (it's free!)
Amcor's narrative projects $23.9 billion revenue and $1.6 billion earnings by 2029. This requires 2.6% yearly revenue growth and an earnings increase of about $0.9 billion from $678.0 million today.
Uncover how Amcor's forecasts yield a $48.21 fair value, in line with its current price.
Exploring Other Perspectives
Before this news, the most optimistic analysts were assuming Amcor could lift earnings to about US$1.6 billion by 2029, helped by Berry synergies and stronger margins; the latest segment growth forecasts may either reinforce that upside story or, if execution on integration and divestments proves harder than expected, highlight why other investors see the risks very differently.
Explore 6 other fair value estimates on Amcor - why the stock might be worth as much as 67% more than the current price!
Decide For Yourself
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
- A great starting point for your Amcor research is our analysis highlighting 2 key rewards and 4 important warning signs that could impact your investment decision.
- Our free Amcor research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Amcor's overall financial health at a glance.
Ready For A Different Approach?
The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:
- Capitalize on the AI infrastructure supercycle with our selection of the 55 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
- Invest in the nuclear renaissance through our list of 89 elite nuclear energy infrastructure plays powering the global AI revolution.
- We've uncovered the 8 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com